ICL 6.1: Hyperbilirubinemia Flashcards
what is the overview of the heme to bile pathway?
heme moiety –> tetrapyrrole biliverdin + Fe via heme oxygenate
then tetrapyrrole iliverdine –> bilirubin via billiverdine reductase
bilirubin is insoluble so it has to form a complex with albumin to travel through the blood to get to the liver
once it gets to the liver, they dissociate and bilirubin is picked up by OATP and goes to the cytosol where it’s glycerolized:
unconjugated bilirubin + UDP-glucuronic acid–> bilirubin monoglucuronides (BMG) via UDP-glucuronosyl-transferase
BMG 00> bilirubin diglucuronides (BDG)
then BMG and BDG go to tile in the bile canalicculi in the gallbladder via MRP-2 protein to make bile which is turned into urobilinogen which is then reabsorbed via portal circulation where it re-enters the liver and enters the secretory cycle again –> some urobilingoen stays in the large intestine where it is oxidized into stercobilin that makes our poop brown!!
other urobilinogen since it’s water soluble and goes to the kidney and turns pee yellow!
some of the BMG and BDG is regurgitated back in the blood sinusoid but ultimately most of it ends up back in the liver
what is jaundice?
a yellow discoloration of the skin, mucous membranes and sclera
jaundice is the clinical manifestation of increased bilirubin in the plasma, hyperbilirubinemia above 3-4mg/dL
hyperbilirubinemia below 3mg/dL may not be detected clinically
jaundice is the most common clinical manifestation of liver diseases
jaundice is usually, but not always, associated with pruritis (itching)
what are the dynamics of bilirubin binding to albumin in hyperbilirubinemic states?
bilirubin at concentration of 25mg/100 ml or below binds to albumin at the high affinity binding sites – so there’s plenty of albumin to carry all the bilirubin
bilirubin at concentration higher than 25mg/100 ml binds to albumin at the low affinity binding sites which is a weak bond and can be easily displaced by:
1. sulfonamides
- some analgesics
- ethacrynic acid
- furosemide
these are also carried by albumin to the liver and they displace bilirubin in hyperbilirubinemia and can manifest jaundice
what are the etiological types of jaundice?
- hemolytic hyperbilirubinemia (prehepatic)
- hepatocellular hyperbilirubinemia (Hepatic)
- obstructive or cholestatic hyperbilirubinemia (post-hepatic)
how do you classify jaundice based on the fraction of bilirubin is elevated?
- unconjugated hyperbilirubinemia
- conjugated hyperbilirubinemia
- mixed hyperbilirubinemia
what are the mechanistic types of jaundice?
- increased bilirubin production
- decreased bilirubin disposition (hepatocellular dysfunction)
- decreased bile flow (cholestasis)
- intrahepatic
- extrahepatic - inherited or acquired defects in specific aspects of hepatic bilirubin disposition
what is the mechanism of increased bilirubin production?
increased hemolysis = an accelerated destruction of transfused erythrocytes that leads to an increase in bilirubin production that is more than the liver can handle
in normal liver, bilirubin detoxification system is highly efficient in handling mild to moderate hemolysis and the hyperbilirubinemia is mild and rarely exceeds the 4mg/dL
so for hemolysis alone to manifest as jaundice, it has to be severe hemolysis (hemolytic crisis)
ex. massive blood transfusion, absorption of a hematoma, favism
prolonged hemolysis may lead to the formation of bilirubin gallstones, which may be complicated by obstructive jaundice
what conditions could cause increased rates of bilirubin production?
- resorption of hematomas
- ineffective erythropoiesis owing to lead poisoning
- membrane abnormalities (spherocytosis and elliptocytosis)
- hemoglobin abnormalities (Thalassemia and sickle cell anemia)
- megaloblastic anemias related to deficiency of either folic acid or vitamin B12, sideroblastic anemia
- infections, sepsis
- congenital erythropoietic porphyria
- myeloproliferative or Myelodysplastic diseases.
- RBC enzyme deficiency (G-6-PD Deficiency)
- autoimmune
when does mild or moderate hemolysis manifest as jaundice?
it normally doesn’t, you just have signs of anemia
for mild hemolysis to manifest as jaundice you have to have a compound problem like
- an associated liver dysfunction
- taking medications that will displace bilirubin from its binding sites on albumin = sulfonamide, analgesics, ethacrynic acid, furosemia
- selected drugs can interfere with hepatocellular uptake of bilirubin = rifampin and the immunosuppressive agent cyclosporine
what conditions can cause decreased hepatic disposition of bilirubin/hepatocellular dysfunction?
- infections
- toxic
ex. isoniazid, alpha-methyldopa, acetaminophen - metabolic diseases
- vascular
- inflammation of intrahepatic bile ductules
ex. chlorpromazine, erythromycin - granulomatous disease
- neoplasm
- miscellaneous
ex. contraceptive jaundice, estrogen,s anabolic steroids
what are the intrahepatic cholestasis causes of decreased bile flow?
- familial colestatic disorders
- diffuse infiltrative disorders
- inflammation of intrahepatic bile ductules and/or portal tracts
what are the extrahepatic cholestasis causes of decreased bile flow?
- choledocolithiasis
- bile duct disease
- inflammation, infection
- neoplasm: cholangiocarcinoma
- extrinsic compression: [ancreatic carcinoma, metastatic lymphadenopathy, hepatocellular carcinoma, ampullary adenoma/carcinoma, lymphoma
- pancreatitis
- vascular enlargement: aneurysm, cavernous transformation of the portal vein (portal cavernoma)
what are the inerheited or acquired defects in specific aspects of hepatic bilirubin disposition/isolated disorders of bilirubin metabolism?
- hepatocellular bilirubin uptake involves both facilitated transport (OATP1B1) and simple diffusion components.
disease: Gilbert Syndrome: secondary mechanism effecting bilirubin conjugation - drugs: several drugs competitively inhibit the transporter protein OATP1B1
- rifampin
- novobiocin
- immunosuppressive cyclosporin
- cholecystographic contrast agents
what conditions can cause decreased conjugation of bilirubin?
- Gilbert syndrome
- Crigler-Najjar syndromes
- physiologic jaundice of the newborn
- drugs (HIV protease inhibitors, e.g., indinavir, atazanavir)
how is bilirubin conjugated? which diseases effect this?
bilirubin conjugation with glucuronic acid is catalyzed principally by a specific UDP-GlucuronosylTransferase, which is designated UGT1A1 and encoded by theUGT1gene complex
three autosomally inherited disorders of unconjugated hyperbilirubinemia are due to impaired bilirubin conjugation:
- Gilbert Syndrome
- Crigler-Najjar Syndrome type 1
- Crigler-Najjar Syndrome type 2
what is Gilbert syndrome?
Gilbert syndrome is a hereditary (autosomal recessive) form of unconjugated hyperbilirubinemia and has a prevalence of approximately 7-10% in white populations.
the molecular basis of Gilbert syndrome has been linked to missense mutations in the promoter region and, less commonly, in the coding region.
patients with Gilbert syndrome have 10 to 33% of normal enzymatic activity, leading to bilirubin 1.5 to 3 mg/dL
Gilbert syndrome is generally benign condition and requires no treatment.
clinical jaundice is uncommon and the patient is asymptomatic and the isolated hyperbilirubinemia is incidentally discovered in routine blood work
serum bilirubin levels may rise 2- to 3-fold with fasting or dehydration but are generally below 4 mg/dL.
patient with Gilbert syndrome has increased risks for:
- gallstones
- toxicity of selected drugs like irinotecan that require glucuronidation for metabolic disposal
on the other hand, patients with Gilbert syndrome may be at decreased risk for cardiovascular disease and certain neoplasms (bilirubin is antioxidation regulatory molecule)